Colecalciferol

ApprovedSmall molecule

UUniversity of Turku

Colecalciferol is one of 34 small molecule programs targeting Vitamin D Deficiency. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Vitamin D DeficiencyActive, not recruiting

Multiple SclerosisActive, not recruiting

Vitamin D DeficiencyPhase 2

Active, not recruiting

Multiple SclerosisApproved

Active, not recruiting

Competition

Competitive Landscape

560 competitors in Multiple Sclerosis

#DrugCompanyPhaseTrials

Colecalciferol

UUniversity of Turku

Approved

2 2

Kesimpta

Novartis

Preclinical

15 3

Tysabri

Biogen

Preclinical

14 4

Zinbryta

Roche

Preclinical

2 5

Pred Forte

Myfortic

Novantrone

Circadin

NNeurim Pharmaceuticals Ltd.

Preclinical

3 9

Pletal

Otsuka

Preclinical

1 10

Wellcovorin

GGlaxo Dba Glaxosmithkline

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Multiple Sclerosis2 trials

Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)

Unknown status·UUniversity of Turku·Phase 4·NCT01339676·70 enrolled

Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)

Completed·UUniversity of Turku·Phase 2/3·NCT01432704·70 enrolled

Vitamin D1 trial

Vitamin D Substitution During Winter Time

Unknown status·FFaculty Hospital Kralovske Vinohrady·Phase 4·NCT02958501·176 enrolled

Testosterone1 trial

Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors

Terminated·UUniversity of Zurich·Phase 3·NCT02419105·91 enrolled

Dialysis Patients1 trial

Evaluation of Colecalciferol Substitution in Dialysis Patients

Completed·UUniversity Hospital, Saarland·N/A·NCT00397475·50 enrolled

Vitamin D Deficiency1 trial

The Prevalence of Vitamin D Deficiency and Effects of Vitamin D Supplementation in HIV-1 Infected Patients

Unknown status·RRadboud University Medical Center·Phase 2·NCT00306410·85 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Colecalciferol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Colecalciferol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Colecalciferol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Turku company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: UUniversity of Turku

Colecalciferol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Multiple Sclerosis2 trials

Vitamin D1 trial

Testosterone1 trial

Dialysis Patients1 trial

Vitamin D Deficiency1 trial

References

Drug Info

Quick Facts

Related News